Raymon Heather (CIK 2028466) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Sell ARTV (3,095 shares), Buy ARTV (46,000 shares), Sell ARTV (1,521 shares), Buy ARTV (67,253 shares), Sell ARTV (1,375 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Sell | 3,095 | $27,879 |
| 2026-02-18 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Buy | 46,000 | $0 |
| 2026-02-18 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Sell | 1,521 | $6,084 |
| 2025-12-12 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Buy | 67,253 | $0 |
| 2025-11-17 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Sell | 1,375 | $4,469 |
| 2025-08-18 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Sell | 745 | $1,587 |
| 2025-08-18 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Sell | 1,639 | $4,507 |
| 2025-02-28 | Artiva Biotherapeutics, Inc. (ARTV) | SVP, Research and Development | Buy | 33,350 | $0 |
Source: SEC Form 4 filings · as of 2026-05-19